Cargando…
A novel lipid metabolism-related lncRNA signature predictive of clinical prognosis in cervical cancer
Background: Cervical cancer (CC) is a serious threat to women populations worldwide. Lipid metabolism is believed to have modulating functions in cancer. Long non-coding RNAs (lncRNAs) are potential biomarkers for the different tumor prognosis. Our work aims at investigating the prognostic value of...
Autores principales: | Lu, Yanzhen, He, Xiujun, Fang, Xia, Chai, Ningxia, Xu, Fangfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621320/ https://www.ncbi.nlm.nih.gov/pubmed/36324514 http://dx.doi.org/10.3389/fgene.2022.1001347 |
Ejemplares similares
-
Six-lncRNA Immune Prognostic Signature for Cervical Cancer
por: Chen, Qian, et al.
Publicado: (2020) -
Amino Acid Metabolism-Related lncRNA Signature Predicts the Prognosis of Breast Cancer
por: Dai, Yin-wei, et al.
Publicado: (2022) -
Construction and comprehensive analysis of a curoptosis-related lncRNA signature for predicting prognosis and immune response in cervical cancer
por: Liu, Li, et al.
Publicado: (2023) -
A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer
por: Du, Xinyi, et al.
Publicado: (2022) -
Prediction of Recurrence in Cervical Cancer Using a Nine-lncRNA Signature
por: Mao, Yu, et al.
Publicado: (2019)